A Study of Pembrolizumab in Combination With Epacadostat in Women With Recurrent/Metastatic Endometrial Carcinoma
Clinical trial NCT03310567 · WITHDRAWN
Trial details
- NCT number
- NCT03310567
- Sponsor
- Fox Chase Cancer Center
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-01
- Primary completion
- 2018-09-10
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.